• Home
• Products
  • Product Overview
  • Mastitis Management
    • Wipe Out^®
    • CMT
    • MASTiK^®
    • Mast Out^®
  • Calf Health
    • First Defense^®
    •  
• How to Order
  • First Defense^®
  • CMT
  • Wipe Out^®
  • MASTiK^®
  • International
• Exhibits & Conferences
• Investor Relations
  • Quick facts & Stock Information
  • Financial Information
  • Products & Licensing
  • Corporate Governance
  • Industry News & Events
• Careers
• Contact

Investor Relations

 

Business Ethics

• ICCC Code of Conduct
• Charter and Powers of the Audit Committee

 

 

 

 

 

 

ImmuCell is a public biotechnology company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries. Our product focus encompasses prevention, diagnosis and treatment of economically important bovine diseases.

Investor Relations:
Michael F. Brigham
President & CEO
ImmuCell Corporation
56 Evergreen Drive
Portland, Maine 04103
207-878-2770
mbrigham@immucell.com

For up-to-date quotes:

• FlashQuote
• Yahoo Finance
• InfoQuote